Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Search
Artificial Intelligence and the Future of Healthcare
This video series explores how artificial intelligence (AI) will change the future of healthcare. Eric Topol, MD, cardiologist, founder and director of The Scripps Research Translational Institute, and author of “Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again," offers unique insight on how AI can return the humanity to medicine and strengthen the patient-physician relationship.
The Doctors Company Receives Datos Insights 2025 Impact Award for Insurance Innovation
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, part of TDC Group, announced today that it has received a 2025 Datos Insights Impact Award for Insurance Innovation. The awards program recognizes organizations that demonstrate excellence in implementing innovative technology solutions that drive measurable business results and industry leadership.
Dec 02, 2024
Foundation Announces 2024 Grant Recipients
The Doctors Company Foundation awarded three new grants in 2024.
From
The Doctor’s Advocate
Fitch Ratings Affirms ‘A’ Ratings, ‘Stable’ Outlook for The Doctors Company
June 30, 2025: Fitch Ratings has affirmed its “A” (Strong) Insurer Financial Strength ratings for The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group. The outlook of these ratings is “Stable.”
Sep 05, 2025
An Updated Approach to Perioperative Management of Patients Undergoing Noncardiac Surgery: Cleared for Take-Off?
The new guideline for evaluating surgical patients for cardiovascular risk promotes a multidisciplinary approach that can help improve patient outcomes.
From
The Doctor’s Advocate
Minor Consent: Challenges for Pediatric Dentistry
Identifying a minor patient’s legal guardianship and parental rights prior to initial treatment can help dental practitioners reduce risk.
Oct 26, 2023
Guided Risk Self-Assessment Exclusively for Member Practices
The Guided Risk Self-Assessment contains risk mitigation strategies to assist healthcare professionals in medical or dental offices. This program will help practitioners and their staff develop a comprehensive understanding of practice risks and learn specific actions to prevent patient injuries and professional liability claims.
March 01, 2024, Healthcare Risk Management
AI Creates Liability Risks for Healthcare Organizations
Sue Boisvert, BSN, MHSA, CPPS, CPHRM, DFASHRM, Senior Patient Safety Risk Manager, Department of Patient Safety and Risk Management, The Doctors Company, part of TDC Group, discusses how artificial intelligence (AI) is becoming more common in healthcare, and while it offers substantial benefits, there are serious risks to consider.
October 11, 2022, KevinMD
Primary Care 2.0: New Thinking and Practice Redesign
Megan Mahoney, a family physician and member of the Board of Governors of The Doctors Company and TDC Group, explains the several principles that have informed her primary care practice team’s thinking about practice redesign.
